Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,479 transcripts · 1,653 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 213 of 290 · 3,479 calls

  • Uber Technologies (UBER) Q2 2025 earnings call

    Management framed the call around broadening platform engagement, accelerating autonomous supply, and returning substantial cash while keeping core execution strong.

    Aug 06, 2025Confident0.86
  • Novo Nordisk A S (NVO) Q2 2025 earnings call

    Management framed the outlook cut as a serious execution challenge, while incoming CEO Mike Doustdar emphasized sharper focus, faster execution and cost reallocation.

    Aug 06, 2025Cautious-0.15
  • Accel Entertainment (ACEL) Q2 2025 earnings call

    Management framed localized gaming growth, operational scaling, and disciplined M&A as reinforcing long-term EBITDA and free-cash-flow expansion.

    Aug 05, 2025Confident0.82
  • Hudson Pacific Properties (HPP) Q2 2025 earnings call

    Management framed West Coast leasing and studio restructuring as turning points, with balance-sheet repair largely complete and execution shifting toward occupancy and cash-flow recovery.

    Aug 05, 2025Confident0.72
  • Oaktree Specialty Lending (OCSL) Q3 2025 earnings call

    Management emphasized balance-sheet repair, selective first-lien deployment and gradual earnings recovery through higher leverage and redeployment of non-earning assets.

    Aug 05, 2025Positive0.55
  • ADTRAN Holdings (ADTN) Q2 2025 earnings call

    Management framed Q2 as broad-based recovery becoming self-sustaining, with optical normalization, cross-selling and operating leverage increasingly supporting second-half confidence.

    Aug 05, 2025Confident0.82
  • New Jersey Resources (NJR) Q3 2025 earnings call

    Management emphasized durable utility-led growth, flexible capital deployment, and regulatory progress despite unresolved tax-bill and rate-case details.

    Aug 05, 2025Confident0.78
  • Encompass Health (EHC) Q2 2025 earnings call

    Management framed demand, capacity expansion and disciplined execution as supporting another guidance increase despite second-half startup and cost headwinds.

    Aug 05, 2025Confident0.82
  • Pfizer (PFE) Q2 2025 earnings call

    Management framed the quarter as evidence that commercial execution and cost controls are improving, while policy uncertainty and COVID volatility tempering further guidance increases.

    Aug 05, 2025Positive0.45
  • Caterpillar (CAT) Q2 2025 earnings call

    Management framed stronger demand and backlog momentum against a more material tariff headwind, while keeping mitigation timing and 2026 deliberately open.

    Aug 05, 2025Positive0.55
  • Orthofix Medical (OFIX) Q2 2025 earnings call

    Management framed Q2 as disciplined profitable growth, with Spine channel changes and Orthopedics innovation setting up stronger second-half execution.

    Aug 05, 2025Confident0.82
  • Molson Coors Beverage (TAP) Q2 2025 earnings call

    Management framed the downgrade as cyclical macro softness compounded by aluminum-cost volatility and modest share underperformance, while defending long-term brand investments.

    Aug 05, 2025Cautious-0.35

Companies covered

1,653 companies

157 more under A